Clinico-Pathological Conference (CPC) Meet

Slides:



Advertisements
Similar presentations
MALIGNANT OVARIAN TUMOUR
Advertisements

NEPHROBLASTOMA (WILM’S TUMOR)
The Anatomy of Collaborative Staging: Ovary Presentation developed by Collaborative Staging Steering Committee 2005 Update.
Pelvic Masses & Ovarian Cancer. Differential diagnosis of pelvic masses Investigations and management Benign ovarian cysts Ovarian cancer.
Pelvic Pain Mr James Campbell.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
Pelvic Ultrasound By. Alaa Malki.
Endometrial Cancer Tseng Jen-Yu 02/05/2007 Tseng Jen-Yu 02/05/2007.
Abnormal Vaginal Bleeding in a 56 year old Max Brinsmead PhD FRANZCOG May 2015.
District 1 ACOG Medical Student Teaching Module 2009
Carcinoma of the Endometrium1 CARCINOMA OF THE ENDOMETRIUM Wen Di, M.D. , Ph.D.
Malignant Ovarian Tumors
Post Menopausal Bleeding
Breast Cancer Liz Ignatious, Maddie Ticer, Molly Houlahan.
,, Presence of functioning endometrial glands and stroma outside their usual location ( the uterine cavity) ”.
Women’s Hospital, School of Medicine Zhejiang University Prof. Lin Jun
Ovarian tumours.
Endometrial Cancer ASSOCIATE PROFESSOR Iolanda Blidaru MD, PhD.
Gynaecologische Tumoren: Internationale richtlijnen en Nieuwe perspectieven in diagnostiek en behandeling SYMPOSIUM ONCOLOGIE – 7 JUNI 2008 Philippe Van.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
Case Study 63: Cancer of the Female Breast
Department of pathology Prof:- Adiga. Student name :- Saeed Ayed saed Abdulrahman Awagi Alnami Muhannad Ali Asiri Faris.
Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.
Ovarian tumor Wei Jiang, M.D., Ph.D. Attending of Ob & Gyn Ob & Gyn Hospital, Fudan University 419 Fangxie Road, Shanghai -----From.
Ovarian Tumours Max Brinsmead MBBS PhD November 2014.
BY DR. KHANSA IQBAL SENIOR REGISTRAR GYNAE UNIT-II.
Quang Truong Mr. Kashub 2nd Session
Computed tomography scan of the abdomen shows a large cystic mass in the abdomen and pelvis without solid tissue or septations (measurement: 43×20×31-cm.
Sex Part 2.
Endometrial Carcinoma
IRIA 67th Annual Conference
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan.
Ovarian cancer Karima salama.
WANDERING OVARY DR. J.CHITRA M.D, DGO, D.NB ASST PROFESSOR KANYAKUMARI GOVT MEDICAL COLLEGE.
TEMPLATE DESIGN © Endometrial large cell neuroendocrine carcinoma : a case report Reina Sato, Aiko Kawano, Hiroyuki Shigeta.
Principles of Surgical Oncology Done by : 428 surgery team surgery team.
Female Genital Tract I Case 2 HISTORY: Pt is a 27-year-old woman who presents with the inability to conceive a child during the past five years. PHYSICAL.
Tumours of the testis 1. Introduction ❏ any solid testicular mass in young patient – must rule out malignancy ❏ slightly more common in right testis (corresponds.
Early Pregnancy Loss and Ectopic Pregnancy
17 th century microscopes In The Name of God PARISA REZAEI,M.D.,AP.CP.
REVISED FIGO STAGING SYSTEMS FOR GYNAECOLOGICAL CANCERS (2009) Glenn McCluggage, Belfast Trust.
Ovary and Primary Peritoneal Carcinoma Anatomic sites of the ovary and peritoneum. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas,
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Pathology.
Definition Signs & symptoms Treatment Root of the disease.
Inflammation Case Presentation
Welcome to Weakly seminar Dr. Shubha Prasad Das Intern Doctor Dept. of Gynaecology and Obstetrics.
Endometriosis د. نجمه محمود كلية الطب جامعة بغداد فرع النسائية والتوليد.
Rahimullah Khattak Final Year MBBS  Anatomy of the Ovary  Classification  Incidence  Risk Factors  Spread and Screening  Signs and Symptoms 
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Consultant Obstetrician & Gynaecologist
부산대학교병원 김 주 연 2012 년 세포병리학회 가을학술대회 월례집담회.  F/52  Past history : 03’ left breast operation, on follow up  Lower abdominal pain (12’ April)  Physical.
Metastatic Tumors of Ovary. METASTATIC TUMOR FROM BREAST CANCER both ovaries replaced by pale, rather nodular tumor, with breast cancer cells arranged.
Endometriosis, Fibroids, PCOD Dr: Salah Ahmed. Endometriosis - presence of endometrium (glands and stroma) outside the uterine cavity - occurs in as many.
Fallopian Tube Anatomic site of the fallopian tube. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer,
Evaluation of renal masses
case report Title: uterine mass Master: Dr.Mahzooni Resident: Dr.Soleimani 92/7/6.
Case Report Disseminated Granulomatous disease of peritoneal cavity presenting as carcinomatosis Rule of diagnostic laparoscopy.
Intravascular leiomyomatosis (A rare case report)
Dr . Saadeh Jaber OBGYN consultant 2010
Post Menopausal Bleeding
FALLOPIAN TUBE CARCINOMA – A CASE PRESENTATION PATHOLOGICAL FINDINGS
Male and Female Reproductive Health Concerns
Uterine cancer Uterine mesenchymal neoplasms
Dr Amit Gupta Associate Professor Dept of Surgery
Uterine Leiomyomas. Uterine Leiomyomas Most common benign uterine tumors Location :uterus ,cervix ,broad ligament Subserosal Intramural Submucosal.
ENDOMETRIAL CARCINOMA
Maffucci Syndrome And Associated Morbidities
RETROPERITONEAL NON-FUNCTIONING PARAGANGLIOMA: A DIFFICULT TUMOR TO DIAGNOSE AND TREAT GENERAL SURGERY DEPARTMENT I HMIMV.
Fallopian Tube Cancer Paweł Sadłecki
Presentation transcript:

Clinico-Pathological Conference (CPC) Meet Karpagam Medical College Hospital 30-01-2015

Case History 37 yr. old female Puberty at 14 yrs Regular menstrual cycles 3-4/30 Married at 17 yrs Para 2 Live 2 MTP1 First Child -17 yrs, FTND, A&W Second Child – 19 yrs, FTND, A&W Sterilisation done . LCB – 14 yrs

Chief Complaints Increased , continuous , and painless bleeding Per vaginum - 1 month Cycles usually regular, once in 30 days, lasts for 3-4 days Discomfort in the lower abdomen – 1 month Bowel and micturition habits – normal No loss of appetite/weight Feeling of extreme lassitude

General Examination Moderately built and nourished Severe anemia No jaundice or cyanosis No significant lymphadenopathy Vital signs -Normal

Abdominal Examination Fullness in the lower abdomen No enlarged veins over the abdominal wall Swelling midline, about 8-10 cm in size, uniform surface , non tender, firm to hard in consistency , Mobile – side to side No free fluid

Pelvic Examination The exact size of uterus could not be made out Swelling not palpable bimanually No rectal nodes

Investigations BLOOD GROUP - AB+ve Hb - 8 gm% Platelets count – 5.64 lakhs/cu.mm Serology - Normal Renal function tests – Normal TSH- 0.55 IU/ml CA- 125 = 25.5 U/ml ECG, X-ray Chest PA - Normal

Ultrasound Abdomen Bulky Uterus - 9.1 x 6.6 x 6.1 cm Thickened Endometrium - 2.0 cm ?Endometrial hyperplasia/polyp Thick walled cystic area in right adnexa ?Cystic ovarian mass ?Broad ligament myxoma with degeneration

Differential Diagnosis OVARIAN CYST FIBROID UTERUS -? BROAD LIGAMENT ABNORMAL UTERINE BLEEDING WITH

Gross Appearance Specimen of Total Abdominal Hysterectomy with Bilateral Salphingo-oopherectomy (11x6x5cm). Cross Section of the uterus – unremarkable.

Gross Appearance Right ovary is cystic and ms (9x9x4.5cm) Cross Section: Variegated, solid and cystic growth (9x8.5x4.5cm)

Gross Appearance Left ovary (3x2x1cm) showed multiple cysts Both tubes were unremarkable

Microscopy Patterns - microfollicular, trabecular and macrofollicular Proliferation malignant cells having round to oval nuclei , scanty cytoplasm Some of these cells have prominent nucleoli and nuclear grooving Foci showing Call-Exner bodies and hemorrhagic areas are also seen.

Microscopic Picture Call-Exner bodies

Microscopic Picture

Differential Diagnosis Granulosa cell tumor Endometrioid tumor Undifferentiated/poorly differentiated tumor

Ovarian tumor staging – FIGO (2014) Stage Definition I Tumor confined to ovaries. IA Tumor limited to one ovary (capsule intact); no tumor on ovarian surface; no malignant cells in the ascites or peritoneal washings. IB Tumor limited to both ovaries (capsules intact); no tumor on ovarian surface; no malignant cells in the ascites or peritoneal washings. IC Tumor limited to one or both ovaries, with any of the following: IC1: Surgical spill intraoperatively. IC2: Capsule ruptured before surgery or tumor on ovarian surface. IC3: Malignant cells present in the ascites or peritoneal washings. II Tumor involves one or both ovaries with pelvic extension (below pelvic brim) or peritoneal cancer (Tp). IIA Extension and/or implants on the uterus and/or fallopian tubes and/or ovaries. IIB Extension to other pelvic intraperitoneal tissues.

Stage Definition III Tumor involves one or both ovaries, or primary peritoneal cancer, with cytologically or histologically confirmed spread to the peritoneum outside of the pelvis and/or metastasis to the retroperitoneal lymph nodes. IIIA Metastasis to the retroperitoneal lymph nodes with or without microscopic peritoneal involvement beyond the pelvis. IIIA(i) Positive retroperitoneal lymph nodes only (cytologically or histologically proven). IIIA(ii) Metastasis >10 mm in greatest dimension. IIIA2 Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. IIIB Macroscopic peritoneal metastases beyond the pelvic brim ≤2 cm in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes. IIIC Macroscopic peritoneal metastases beyond the pelvic brim >2 cm in greatest dimension, with or without metastases to the retroperitoneal nodes.a IV Distant metastasis excluding peritoneal metastases. IVA Pleural effusion with positive cytology. IVB Metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity).

Report Uterus with chronic cervicitis and endometrium with cystoglandular hyperplasia and adenomyosis. Right ovary shows features of Adult Granulosa Cell Tumor – Stage IA (T1a Nx Mx)* Suggested further immuno histochemical studies for alpha-inhibin, CD99 & calretinin for definite diagnosis.

Review of literature Granulosa cell tumors (GCT) were described for the first time in 1855 by Rokitansky. characterized by a prolonged natural history and a tendency to late recurrences. very rare ovarian malignancies; they represent <5% of all ovarian cancers. Limited data is available from India. patients aged

Review of literature Two distinct histological types—adult GCT (AGCT) and juvenile GCT (JGCT) which display different clinical and histopathological features AGCTs are more common; usually seen in perimenopausal and postmenopausal women, peak incidence at 50–55 years JGCTs are rare tumors, representing 5 % of all GCTs and occurring in premenarchal girls and young women characterized by a good prognosis

Review of literature The main immunohistochemical markers expressed by these cells are vimentin, CD99 and alpha inhibin. The serum tumor markers are estradiol, inhibin, and anti-Müllerian hormone.

Review of literature Various factors determine the prognosis. The most important prognostic variable is the stage. Overall survival (approximately 90% at 5 years for early stage) is good, because most tumors are diagnosed early

Review of literature A special feature - appearance of recurrences long after treatment of primary tumour, mean time is 5.6 years. Recurrences after more than 10 years are reported.

TAKE HOME MESSAGE Solid and cystic tumor with combination of yellow tissue and hemorrhage is highly suggestive of Granulosa cell tumor

Thank you